Based on reported financial statement history.
Over longer horizons, Revenue CAGR averages 24.76% over 3 years and 33.68% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Revenue CAGR measures how the company's top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
Haoxi Health Technology Limited (HAO)
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $21.00M.
| Year | Start Revenue | End Revenue | Change | % Change |
|---|---|---|---|---|
| 2026 | $32.80M | $54.83M | +$22.02M | +67.14% |
| 2025 | $48.52M | $32.80M | −$15.72M | -32.39% |
| 2024 | $28.23M | $48.52M | +$20.29M | +71.88% |
| 2023 | $16.16M | $28.23M | +$12.07M | +74.72% |
| 2022 | $12.85M | $16.16M | +$3.31M | +25.76% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q4 FY2026 | 2026-06-30 | $21.00M | N/A | N/A |
| Q2 FY2026 | 2025-12-31 | $33.83M | N/A | N/A |
| Q4 FY2025 | 2025-06-30 | $8.85M | N/A | N/A |
| Q2 FY2025 | 2024-12-31 | $23.95M | N/A | N/A |
| Q4 FY2024 | 2024-06-30 | $25.02M | N/A | N/A |
| Q2 FY2024 | 2023-12-31 | $23.50M | N/A | N/A |
| Q4 FY2023 | 2023-06-30 | $19.07M | N/A | N/A |
| Q2 FY2023 | 2022-12-31 | $9.16M | N/A | N/A |
| Q4 FY2022 | 2022-06-30 | $8.08M | N/A | N/A |
| Q2 FY2022 | 2021-12-30 | $8.08M | N/A | N/A |
| Q4 FY2021 | 2021-06-30 | $6.42M | N/A | N/A |
| Q2 FY2021 | 2020-12-30 | $6.42M | N/A | N/A |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
